Corient Private Wealth’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Buy
+114,152
New +$1.61M ﹤0.01% 1491
2024
Q4
Sell
-22,741
Closed -$482K 2481
2024
Q3
$482K Buy
22,741
+7,600
+50% +$137K ﹤0.01% 1749
2024
Q2
$240K Buy
15,141
+276
+2% +$5.07K ﹤0.01% 2027
2024
Q1
$221K Sell
14,865
-10
-0.1% -$137 ﹤0.01% 2054
2023
Q4
$136K Hold
14,875
﹤0.01% 2122
2023
Q3
$82.9K Sell
14,875
-59
-0.4% -$413 ﹤0.01% 2047
2023
Q2
$120K Sell
14,934
-77
-0.5% -$568 ﹤0.01% 1950
2023
Q1
$98.2K Sell
15,011
-442
-3% -$1.8K ﹤0.01% 1887
2022
Q4
$38K Buy
+15,453
New +$48.3K ﹤0.01% 1645

Other funds holding OSCR

Corient Private Wealth's OSCR Position: Q1 2026 in Review

Corient Private Wealth opened a new position in Oscar Health (OSCR) in Q1 2026: 114,152 shares worth $1.3M. The stake represents ﹤0.01% of the portfolio and ranks #1491 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in OSCR as recently as Q3 2024.

Corient Private Wealth first reported a position in OSCR in Q4 2022 and has held it in 9 quarters since. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Corient Private Wealth held 114,152 shares of Oscar Health worth $1.3M as of Q1 2026.
  • Oscar Health was a new Corient Private Wealth position in Q1 2026.
  • Oscar Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1491 holding.
  • Corient Private Wealth first reported a position in Oscar Health in Q4 2022 and has held it in 9 quarters since.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.